Shanghai TenGen, located in the Biotech & Pharmaceutical Industry Base, ZhangJiang Hi-Tech Park, Shanghai, has attracted the collaboration of many returning outstanding overseas scholars and experts. Shanghai TenGen serves as an incubator of advanced overseas biomedical projects, and a bridge linking TCM and the modern world.
Shanghai TenGen seeks the unique combination between TCM and modern technology. With proprietary techniques, concentrating its endeavors in anticancer and anti-hepatic fibrosis, Shanghai TenGen has developed dozens of TCM agents, which meet stringent modern biomedical standards.
To support its multiple works in new drug R&D, Shanghai TenGen has made all the necessary establishments, including the development and operation of a substantial cell bank and the adoption of Hollow Fiber Assay, an efficient in-vivo screening method for anticancer drug tests, which is recommended by the National Cancer Institute, USA. Shanghai TenGen has also established a pilot scale study base to prepare new drugs for commercial production.
Beijing TenGen utilizes advanced international biotechnology to promote the development of biotechnological applications not only in human medicine and health care, but also in the agricultural and fishery industries. It functions as TenGen BioTech's headquarters, responsible for TenGen BioTech's financial management, setting its development strategy and objectives, coordinating the cooperation among the four affiliates, evaluating prospective projects, and managing the public relations and marketing of TenGen BioTech's products.